Upload
amy-martin
View
227
Download
0
Embed Size (px)
Citation preview
8/13/2019 Dialysis 7
1/63
Dialysis
8/13/2019 Dialysis 7
2/63
Dialysis is the process of removing waste products
and excess fluids from the body
Definitions
Dialysis is on of the primary modalities for pts withRF
Dialysis can do two of the principal functions of the
kidney; 1.removal of endogenous waste products 2.maintenance of water balance
8/13/2019 Dialysis 7
3/63
8/13/2019 Dialysis 7
4/63
Dialysis is the process of separating elements in a
solution by diffusion across a semipermeable
membrane (diffusive solute transport) down aconcentration gradient
This is the principal process for removing the end-
products of nitrogen metabolism (urea, creatinine,uric acid), and for repletion of the bicarbonate
deficit of the metabolic acidosis associated with
renal failure in humans
8/13/2019 Dialysis 7
5/63
Cont
8/13/2019 Dialysis 7
6/63
Advanced renal failure with:
1. Hyperkalemia
2. Fluid overload
3. Severe metabolic acidosis
(PH
8/13/2019 Dialysis 7
7/63
B. Acute dialysis
1. ESRD with or without complications
Cont
8/13/2019 Dialysis 7
8/63
Signs of adequate dialysis;
1. Well looking
2. Eats normal
3. Normal BP4. No oedema
5. Normal heart size
6. HB >=10
7. Albumin >35
8/13/2019 Dialysis 7
9/63
Hemodialysis
8/13/2019 Dialysis 7
10/63
Blood is removed from the body and pumped by a
machine outside the body into a dialyzer (artificial
kidney)
The dialyzer filters metabolic waste products from
the blood and then returns the purified blood to the
person
The total amount of fluid returned can be adjusted
A person typically undergoes hemodialysis at adialysis center
Dialysate is the solution used by the dialyzer
Cont
8/13/2019 Dialysis 7
11/63
HD consists of perfusion of heparinized blood and
physiologic salt solution on opposite sides of a
semipermeable membrane
Waste products (urea, creatinine,ets) move from
blood into the dialysate by passive diffusion along
concentration gradient Diffusion rate depends on;
1. The difference between solute concentrations in the
blood and dialysate2. Solute characteristics
3. Dialysis filter composition
4. Blood and dialysate flow rate
Cont
8/13/2019 Dialysis 7
12/63
Blood from the patient is
circulated through a syntheticextracorporeal membrane and
returned to the patient. The
opposite side of that membrane
is washed with an electrolyte
solution (dialysate) contain- the
normal constituents of plasma
water
Cont
8/13/2019 Dialysis 7
13/63
Cont
8/13/2019 Dialysis 7
14/63
8/13/2019 Dialysis 7
15/63
Dialysate;
1. Water2. Glucose
3. Acetate
4. Bicarbonate
5. Calcium
6. Sodium
7. Potassium
8/13/2019 Dialysis 7
16/63
Used 3 times a week
Duration; 4 hrsComplicated, need to be done in a center
Heparin required
Temporary arteriovenous access
Permanent arteriovenous access
8/13/2019 Dialysis 7
17/63
Access
C t
8/13/2019 Dialysis 7
18/63
The access is where the needles are placed to remove
blood from the body and return it to the body after it
is filtered by the dialysis machine
Three types of accesses exist: natural fistula,
artificial grafts, andjugular vein catheters
A vein and an artery are joined. Within 6 to 8 weeks,
the vein becomes much bigger and is strong enough
to be used as an access for dialysis
Cont
Cont
8/13/2019 Dialysis 7
19/63
How a fistula access works
1.During dialysis, two needles are placed into the fistula.
One needle will remove the blood so it can be cleaned. Theother needle will return filtered blood to the body
2.The needles are attached by plastic tubing to a special filter
called a dialyzer (or artificial kidney)3. A pump pushes the blood through the dialyzer. Blood
passes on one side of the filter, and solution made by the
machine passes on the other side. The blood does not mix
with the solution. Instead, the solution pulls extra fluid and
waste out of the blood by a process called dialysis
4. The "clean" blood returns through the plastic tube. It
passes back into the patient's body through the second needle
Cont
Cont
8/13/2019 Dialysis 7
20/63
A graftis another type of access, which is used
if a person's own veins are too small or weak to
create a fistula. Usually, a graft is a soft,
synthetic tube that connects to an artery at one
end and a vein at the other. It is placed under
the skin of the arm or thigh, like a natural vein.
The patient's blood flows through it, like it
flows through natural veins
Cont
Cont
8/13/2019 Dialysis 7
21/63
Sometimes hemodialysis is needed right away,
and there is no time to create a fistula or graft.
If this happens, a tube called a cathetermaybe inserted into a large vein in the neck
(jugular vein), behind the collarbone
(subclavian vein)or in the groin (femoral
vein). The patient's blood can flow through this
tube
Cont
8/13/2019 Dialysis 7
22/63
Complications;
1. Vascular access
a. Thrombosis
b. infection
2. Procedure relateda. Decrease BP
b. Headache
c. Cramps
d. Fever
3. Long term
a. Cardiovascular diseases
b. Renal bone diseases
c. Aluminum disease
d. Social problems
4. Chronic uraemia
a. Anaemia
b. Infection
c. Gonadal dysfunction
d. Increase BP
Cont
8/13/2019 Dialysis 7
23/63
Cont
Cont
8/13/2019 Dialysis 7
24/63
Cont
8/13/2019 Dialysis 7
25/63
Standard HD
Characteristics:1. Low permeability (low flux)
2. Membranes are made of natural products
(cellulose)
3. Each session takes 4-5 hrs
8/13/2019 Dialysis 7
26/63
Rapid high efficiency HD (RHED)
Characteristics:1. Increase clearance of low molecular weight
solutes (urea)
2. Shorter procedure time
3. Increase blood and dialysate flow rates
4. Clearance of middle and high MW solutesincluding drugs is not increased
8/13/2019 Dialysis 7
27/63
High flux dialysis (HFD)
Characteristics:1. Shares the advantages of RHED
2. Membrane pores are more open
3. Higher clearance rate for middle molecules
4. More expensive
5. Needs experts to avoid large rapid fluid shift
8/13/2019 Dialysis 7
28/63
PeritonealDialysis
Cont
8/13/2019 Dialysis 7
29/63
Th di l i b i th ' itCont
8/13/2019 Dialysis 7
30/63
The dialysis membrane is the person's own peritoneum
The dialysis fluid provides the 'container' in which waste
products and excess water can be removed from the bodyDialysis membrane acts as a filter
It keeps the dialysis fluid and the blood separate from
each other, but it allows certain substances and water topass through it
During dialysis, waste toxins and excess water pass from
the blood into the dialysis fluid, and this is drained out ofthe body after a few hours
A new bag of dialysis fluid is drained in, and the process
is repeated
Cont
Cont
8/13/2019 Dialysis 7
31/63
PD needs to be done every day
PD involves draining dialysis fluid out of, and into
the body (known as an exchange), and leavingdialysis fluid in the body while dialysis takes place
Draining fluid out usually takes around 20 minutes
and draining fluid in takes around 5-10 minutes
The 'used' dialysis fluid, containing the water and
waste (toxins) that the kidneys would normally havepassed into the urine, is drained out of the body
The person then needs to drain between 1.5 and 3
litres of 'new' dialysis fluid into their abdomen
Cont
8/13/2019 Dialysis 7
32/63
The dialysis fluid is then left inside the peritoneum to
allow dialysis to take place. The length of time it is
left there varies (between 1 and 8 hours), dependingon individual requirements and the type of PD
There are no 'set' times to carry out the exchanges
It is easy for people to adapt the timing of
exchanges to their own needs. For example, if a
person wants to go out for the day, they could
delay the mid-day exchange, and do two 'quickbags' (say, 3 hours apart) after they come home
Cont
8/13/2019 Dialysis 7
33/63
A four-bag regime 'fits' into a typical day
For example,
The first bag might be exchanged before breakfast
The second before lunch
The third before the evening meal
The fourth before going to bed (leaving the fluid
for the last exchange in through the night)
Cont
8/13/2019 Dialysis 7
34/63
A plastic tube is permanently inserted into the abdomen
This tube is called a PD catheter
It is about 30 cm (12 in) long and as wide as a pencil
The PD catheter is placed through the lower abdominal
wall, into the peritoneal cavity
Half of the catheter lies inside the abdomen, and half lies
outside the body
It comes out to one side of the navel (belly button)
The PD catheter acts as a permanent pathway into the
peritoneal cavity from outside the body
Cont
8/13/2019 Dialysis 7
35/63
Cont
8/13/2019 Dialysis 7
36/63
The catheter is usually 'left alone' for 5 days or more
after the operation before it is used for dialysis
This allows it to 'settle in' and gives the abdominalwound time to heal
PD could be done at home
Much less efficient than HD, this is why it is used
more frequent
Cont
8/13/2019 Dialysis 7
37/63
Di l t
8/13/2019 Dialysis 7
38/63
Dialysate;1. Water
2. Glucose
3. Dextrose;1.5-4.25%
4. Acetate
5. Bicarbonate
6. Calcium;3.5 or 2.5 mEq/l
7. Chloride;102mEq/l
8. Lactate;35mEq/l
9. Magnesium;1.5mEq/l
10. Sodium;132mEq/l to reduce themovement of sodium from the blood by
gradient method
11. No potassium in PD
12. High osmolarity;350-480mOsm/L(serum=280mOsm/l) to provide a drawing force
from the blood into the peritonium
PET it l ilib i t t
8/13/2019 Dialysis 7
39/63
PET; peritoneal equilibrium test
Is a diagnostic test that determines the peritoneal
membrane clearance and ultrafiltrationcharacteristics, and quantitates the ability to transfer
solutes and water across the membrane
PET results determine which type of PD isappropriate for each individual
Indications;
8/13/2019 Dialysis 7
40/63
Indications;
1. DM
2. No vascular access
3. CVS unstable
4. Children
5. Old adults
6. Pts unwilling to accept blood transfusion
7. Severe anaemia
8. Severe HD related symptoms e.g disequilibrium
8/13/2019 Dialysis 7
41/63
Contraindications;
1. Peritonea adhesion
2. Severe lung disease
3. Abdominal sepsis
4. Massive polycystics
8/13/2019 Dialysis 7
42/63
Complications;
8/13/2019 Dialysis 7
43/63
Complications;
a. Malnutrition
b. Peritonitis:
c. 70% Gm positive cocci
d. IP antibiotic is preferred
e. vancomicin or aminoglycosides. First dose in
the first 2L exchange, scond dose at day 7
f. Gentamicin 1.5 mg/kg IP in the first 2L
exchange followed by 4-8 mg/L IP in each
exchange for 10 days
Cont
8/13/2019 Dialysis 7
44/63
Cont
8/13/2019 Dialysis 7
45/63
Cont
8/13/2019 Dialysis 7
46/63
8/13/2019 Dialysis 7
47/63
Pharmacokinetics
of dialysis
8/13/2019 Dialysis 7
48/63
Factors affecting drug dialysability;
1. Drug characteristicsA. MW; drugs with MW >500 are not dialyzable in
the conventional HD. E.g vancomicin, digoxin
Using high flux HD; the above mentioned drugs are
dialyzable
B. Water solubility; solutes which are insoluble in
water will not easily move into aqueous dialysate,
e.g glutethimide
Cont
8/13/2019 Dialysis 7
49/63
D. Volume of distribution; drugs with large VD are
not appreciably removed by HD, e.g digoxin,
aminoglycosides
E. Protein binding; only unbound drugs can pass
through the dialyser membrane, e.g phenytoin,
propranolol, oxacillin
Cont
8/13/2019 Dialysis 7
50/63
2. Dialysis conditions
A. Counter-current vs concurrent flow
B. Blood flow rate
C. Dialysate flow rate
3. Membrane characteristics
A. Thickness
B. Material type / pore size
C. Surface area
Cont
8/13/2019 Dialysis 7
51/63
Clearance of large MW drugs depends on pore size,
surface area and flow rate
Therapeutic considerations
8/13/2019 Dialysis 7
52/63
Therapeutic considerations
1. Supplementary dose should be administered post
dialysis. If the drug is administered at the
beginning of HD, the fraction would be removed,
since it is not yet distributed in the body
2. Drugs with NTW, plasma level should be
monitored to verify the predicted estimation
3. Drugs with wide therapeutic window, decisionbased on pts clinical status
4 Bl d l h ld b d l 1 h
8/13/2019 Dialysis 7
53/63
4. Blood sample should be drawn at least 1 hr post
dialysis to allow redistribution from the tissue,
other references recommend 6-12 hrs postdialysis
5. Drugs which plasma concentration can be
measured but some times no published data onthe pharmacokinetic of certain drugs. if the
pharmacokinetics are known then replacement
dose could be calculated6. Drugs with wide therapeutic range and serum
concentration cannot be measured; single daily
dose can be administered after dialysis
C t i f d di l bilit
8/13/2019 Dialysis 7
54/63
Categories of drug dialyzability;
1. Dialyzable; 50% - 100% removed
2. Moderately dialyzable; 20% - 50%
removed
3. Slightly dialyzable; 5% - 20% removed
4. Not dialyzable;
8/13/2019 Dialysis 7
55/63
Estimating the supplementary dose in dialysis pt
1. The supplementary doses can be calculated
from the pharmacokinetic data reported in theliterature
2. The equations and pharmacokinetic utilized are
based only on linear first order kinetics and one
compartment model
3. More complex kinetics seem to be unnecessaryfor general dosage recommendations for
repeatedly administered drugs
4 F t di l i th t t l l f th d
8/13/2019 Dialysis 7
56/63
4. For pts on dialysis; the total clearance of the drog
from the plasma (ClT) can be defined as the sum of
the pts residential endogenous clearance and thedialysis clearance (ClD)
i.e ClT= Cl + ClD
If ClD>>>Cl then the drug will be eliminated much
more rapidly during dialysis
t1/2 0.693 X VD
ClT=
Clearance can be related to half l i fe by the fol lowing equation
8/13/2019 Dialysis 7
57/63
t1/2 0.693 X VD
Cl + ClD=
VD is the volume of distribution of the drug
The actual amount of drug removed by HD is the
product of the concentration of the drug in the
recovered dialysate and the dialysate volume
XAmount in
dialysate
drug conc. in
dialysate
volume of
the dialysate=
8/13/2019 Dialysis 7
58/63
It is not clinically feasible or analytically practical to
measure dialysate drug concentration
This value divided by total body stores of drug prior
to dialysis yield the actual fraction of drug removed
by dialysis (FD)
FD = amount of dialysate drug / TBs
TBS = drug conc. X VD
The following equation may be used to determine the
8/13/2019 Dialysis 7
59/63
The following equation may be used to determine the
fraction of the total amount of drug in the body
removed during dialysis
FD = 1 - e -(Cl+ClD)(t/VD)
t is the duration of dialysis
To use this equation, the values of Cl, ClD must be obtained
from the literature
Unfortunately, clearance dtat are not alwaysavailable
Half life is more available, so we use another
equation
FD = 1 e -(0.693/t1/2 OD) X (t)
8/13/2019 Dialysis 7
60/63
FD = 1 - e (0.693/t1/2OD) X (t)
t1/2OD is the half life during dialysis
t is the duration of dialysis
This method can be used to calculate the fractionaldrug removed but it is inaccurate
But it is useful in the clinical setting when clearance
data is not available
Example:
8/13/2019 Dialysis 7
61/63
Example:
NN on amikacin, Wt 70 kg
Estimated amikacin Cl 5ml/min (endogenous
clearance)
Under go 4 hr HD (t OD = 4hrs)Calculate the replacement dose for NN??
Assuming VD= 0.2 L/Kg
ClD= 35 ml/min
Answer:
8/13/2019 Dialysis 7
62/63
Answer:
ClT= Cl + ClD
= 5 + 35 = 40 ml/min = 2.4 L/hr
t1/2 0.693 X VD
Cl + ClD=
Then
=0.693 X 0.2L/Kg X 70 Kg
2.4 L/hr
= 4 hrs
8/13/2019 Dialysis 7
63/63
FD = 1 - e -(Cl+ClD)(t/VD)
Or
FD = 1 - e-(0.693/t
1/2OD) X (t)
After we get the answer. It will be replaced
after dialysis